$ENTX 8-K SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
06 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Former Gilead and Amgen executive joins Entera with over 35 years of experience advancing and commercializing impactful and blockbuster therapies
18 Aug 2026	8-K: Regulation FD Disclosure; Other Events
07 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Jul 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
16 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
08 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
03 Apr 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
27 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
04 Mar 2026	8-K: Regulation FD Disclosure
09 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
04 Feb 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
14 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
08 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Jul 2025	8-K: Regulation FD Disclosure; Other Events
18 Jul 2025	8-K: Submission of Matters to a Vote of Security Holders
09 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Mar 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
17 Mar 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
10 Jan 2025	8-K: Financial Statements and Exhibits

Comments